v3.25.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning balance at Dec. 31, 2022 $ 38,818 $ 1 $ 125,861   $ (87,044)
Beginning balance, shares at Dec. 31, 2022   840,002      
Issuance of common stock under ESPP 16   16    
Issuance of common stock under ESPP, shares   700      
Issuance of common stock and pre-funded warrants in PIPE financing, net of issuance costs 24,728   24,728    
Issuance of common stock and pre-funded warrants in PIPE financing, net of issuance costs, shares   606,678      
Issuance of common stock upon vesting of restricted stock units, value (60)   (60)    
Issuance of common stock upon vesting of restricted stock units, net, shares   6,022      
Stock-based compensation 3,284   3,284    
Unrealized gain on available-for-sale securities 4     $ 4  
Net loss (31,476)       (31,476)
Ending Balance at Dec. 31, 2023 35,314 $ 1 153,829 4 (118,520)
Ending balance, shares at Dec. 31, 2023   1,453,402      
Issuance of common stock under ESPP 14   14    
Issuance of common stock under ESPP, shares   958      
Issuance of common stock and pre-funded warrants in PIPE financing, net of issuance costs 49,564 $ 5 49,559    
Issuance of common stock and pre-funded warrants in PIPE financing, net of issuance costs, shares   4,931,389      
Issuance of common stock upon vesting of restricted stock units, value (35)   (35)    
Issuance of common stock upon vesting of restricted stock units, net, shares   7,721      
Stock-based compensation 3,095   3,095    
Unrealized gain on available-for-sale securities 7     7  
Settlement of fractional shares paid in cash (1)   (1)    
Settlement of fractional shares paid in cash, shares   (147)      
Net loss (35,478)       (35,478)
Ending Balance at Dec. 31, 2024 $ 52,480 $ 6 $ 206,461 $ 11 $ (153,998)
Ending balance, shares at Dec. 31, 2024   6,393,323